Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,959 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.
Machado KLLL, Burian APN, Martins-Filho OA, Mill JG, Ferreira LB, Tapia KRL, Moulin ACS, Moulaz IR, Ribeiro PDC, Magalhães VO, Biegelmeyer E, Peixoto FMMMC, Ribeiro SLE, Telles CMPF, Bühring J, Sartorio NS, Hax V, Rezende RPV, Baptista KL, Melo AKG, Cruz VA, Vieira RMRA, Azevedo RH, Azevedo VF, Pinheiro MM, Monticielo OA, Reis Neto ETD, Teixeira-Carvalho A, Xavier RM, Sato EI, de Souza VA, Ferreira GA, Pileggi GS, Valim V. Machado KLLL, et al. Among authors: sato ei. Vaccines (Basel). 2024 Dec 3;12(12):1367. doi: 10.3390/vaccines12121367. Vaccines (Basel). 2024. PMID: 39772029 Free PMC article.
Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.
Fujimoto A, Koutake Y, Hisamatsu D, Ookubo N, Yabuuchi Y, Kamimura G, Kai T, Kozono A, Ootsu T, Suzuki H, Matsuo K, Kuwahara K, Oiwane Y, Nagata Y, Tanimoto K, Sato E, Suenaga M, Uehara T, Ikari A, Endo S, Hiraki Y, Kawamata Y. Fujimoto A, et al. Among authors: sato e. Cancer Immunol Immunother. 2024 Dec 30;74(1):33. doi: 10.1007/s00262-024-03874-4. Cancer Immunol Immunother. 2024. PMID: 39739038 Free PMC article. No abstract available.
PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition.
Pae S, Sedukhina AS, Sugiyama R, Atanacio SJ, Ohara T, Ishii M, Minagawa K, Akichjev R, Go F, Chandankeri Z, Janjetic ZMM, Sato E, Yamaura A, Meguro R, Palanisamy K, Maeda I, Takeuchi O, Suzuki N, Yudo K, Bernal JA, Sato K. Pae S, et al. Among authors: sato e. Sci Rep. 2024 Dec 28;14(1):31276. doi: 10.1038/s41598-024-82724-w. Sci Rep. 2024. PMID: 39732958 Free PMC article.
1,959 results